Carlos Luque-Vásquez
Carlos Luque-Vásquez publishes mostly in Surgery, Oncology and Pulmonary and Respiratory Medicine, on topics such as Pancreatic and Hepatic Oncology Research, Gastric Cancer Management and Outcomes and Colorectal Cancer Surgical Treatments.
- World rank
- #7,076,522 of 7,710,434 ranked researchers
- Rank in Peru
- #6,739 of 7,808
- Works
- 24
- Citations
- 66
- Citations per work
- 2.8
What does Carlos Luque-Vásquez research?
Carlos Luque-Vásquez's work is mostly in Medicine (88%).
Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.
The fields and subfields, with their numbers
- Health Sciences2188.3%
- Medicine2188.3%
- Everything else311.7%
- 1Surgery31% of their works
- 2Oncology22% of their works
- 3Pulmonary and Respiratory Medicine19% of their works
- 4Gastroenterology6% of their works
- 5Cardiology and Cardiovascular Medicine6% of their works
- 6Rheumatology4% of their works
Research topics
- Pancreatic and Hepatic Oncology Research
- Gastric Cancer Management and Outcomes
- Colorectal Cancer Surgical Treatments
- Cardiac, Anesthesia and Surgical Outcomes
- Metastasis and carcinoma case studies
- Gastrointestinal Tumor Research and Treatment
- Helicobacter pylori-related gastroenterology studies
- Cholangiocarcinoma and Gallbladder Cancer Studies
Which keywords describe Carlos Luque-Vásquez's research?
The keywords of their largest research topics: Chemotherapy, Clinical Practice Guidelines, Neoadjuvant Therapy, Gastric Cancer, Endoscopic Resection, Molecular Characterization, Pancreatic Cancer and Surgical Complications.
- Sunitinib
- Imatinib Mesylate
- Cholangiocarcinoma
- Perioperative
- Lung Tumors
- Surgical Management
- Prognostic Factors
- Surgical Complications
- Molecular Characterization
- Gastric Cancer
- Clinical Practice Guidelines
- Chemotherapy
- Neoadjuvant Therapy
- Endoscopic Resection
- Pancreatic Cancer
- Preoperative Chemoradiotherapy
- Rectal Cancer
- Cardiac Risk
- Metastatic Carcinomas
- Biliary Tract Cancer
- Helicobacter pylori
- Inflammation
Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most.
All 22 words, with their numbers
- Chemotherapy142 topics
- Clinical Practice Guidelines132 topics
- Neoadjuvant Therapy132 topics
- Gastric Cancer102 topics
- Endoscopic Resection71 topic
- Molecular Characterization71 topic
- Pancreatic Cancer71 topic
- Surgical Complications71 topic
- Preoperative Chemoradiotherapy61 topic
- Prognostic Factors62 topics
- Rectal Cancer61 topic
- Surgical Management62 topics
- Cardiac Risk41 topic
- Lung Tumors41 topic
- Metastatic Carcinomas41 topic
- Perioperative41 topic
- Biliary Tract Cancer31 topic
- Cholangiocarcinoma31 topic
- Helicobacter pylori31 topic
- Imatinib Mesylate31 topic
- Inflammation31 topic
- Sunitinib31 topic
Where does Carlos Luque-Vásquez work?
Carlos Luque-Vásquez's main affiliation in the publication record is Instituto Nacional de Enfermedades Neoplásicas, Peru.
How many publications and citations does Carlos Luque-Vásquez have?
OpenAlex counts 24 works and 66 citations for Carlos Luque-Vásquez, an h-index of 5, ranking #7,076,522 of 7,710,434 researchers worldwide on the quality score.
Ranked on field-normalised excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.
Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.
Discussion
Ask a question or share a note about Carlos Luque-Vásquez. Posts are plain text and can be reported.